JP2007277149A - Involucrin expression promoter - Google Patents

Involucrin expression promoter Download PDF

Info

Publication number
JP2007277149A
JP2007277149A JP2006105204A JP2006105204A JP2007277149A JP 2007277149 A JP2007277149 A JP 2007277149A JP 2006105204 A JP2006105204 A JP 2006105204A JP 2006105204 A JP2006105204 A JP 2006105204A JP 2007277149 A JP2007277149 A JP 2007277149A
Authority
JP
Japan
Prior art keywords
extract
involucrin
production
stratum corneum
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006105204A
Other languages
Japanese (ja)
Inventor
Takashi Nishijima
貴史 西島
Yoriko Nakagiri
頼子 中桐
Akiyo Kameyama
明代 亀山
Maeko Iwamura
真恵子 岩村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2006105204A priority Critical patent/JP2007277149A/en
Publication of JP2007277149A publication Critical patent/JP2007277149A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an involucrin expression promoter promoting production of the involucrin and promoting keratinization of horny layer cells and to provide a horny layer formation promoter. <P>SOLUTION: The involucrin expression promoter and horny layer formation promoter comprise one or more species of plants selected from the group consisting of Zanthoxylum piperitum, Juniperus communis var. communis, Eucalyptus globulus, Saxifraga stolonifera, Rosmarinus officinalis, Aspalathus linearis, Symphytum officinale, Corthellus cuneata, Acorus calamus, Thymus serpyllum, Sanguisorba officinalis, Uncaria gambir, Ginkgo biloba, Pueraria lobata, Chaenomeles sinensis, Gardenia jasminoides, Eriobotrya japonica, Cinchona succirubra, Crataegus cuneata, Eugenia caryophyllus, Artemisia princeps and Phellodendron amurense Bark or an extract thereof. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、優れたインボルクリンの発現を促進する作用を示すインボルクリン発現促進剤及び角層形成促進剤を提供するものである。   The present invention provides an involucrin expression promoter and a stratum corneum formation promoter that exhibit an action of promoting excellent involucrin expression.

皮膚の水分保持能改善、肌荒れの防止及び改善、並びにしわの形成やきめ模様の減少等の皮膚老化の予防改善には、皮膚の表皮細胞に作用し、表皮細胞の角化を促進し、健全な角層の形成を促して、外界からの刺激や生体を防御するための角層バリア機能を健全にすることがよいとされている。   For improving skin moisture retention, preventing and improving rough skin, and preventing and improving skin aging such as wrinkle formation and texture reduction, it works on skin epidermal cells, promotes keratinization of epidermal cells, and is healthy It is recommended that the formation of a stratum corneum is promoted to make the stratum corneum barrier function for protecting the external stimulus and the living body healthy.

この角層バリア機能の健全には、角層の水分量を保持して角層の柔軟性を維持することが重要であるといわれている。角層バリア機能が低下する原因としては、加齢、乾燥、紫外線等の影響によりターンオーバーが乱れ角層細胞の形成や細胞間脂質の構造に異常が生じることが考えられる。そして、様々な皮膚疾患や肌荒れ等の皮膚トラブルを生じることが知られている。   For the soundness of this stratum corneum barrier function, it is said that it is important to maintain the stratum corneum water content by maintaining the water content of the stratum corneum. As a cause of the decrease in the stratum corneum barrier function, it is considered that the turnover is disturbed due to the effects of aging, drying, ultraviolet rays and the like, and the formation of stratum corneum cells and the structure of intercellular lipids are abnormal. It is known to cause skin problems such as various skin diseases and rough skin.

ここで、ターンオーバーとは、基底層におけるケラチノサイト(表皮角化細胞)の増殖と、角化の過程、角層の剥離の間断ない繰り返しのことをいう。このケラチノサイトは、基底膜細胞、有棘細胞、顆粒細胞、角層細胞と順次外部に向かって角化しながら、各層を形成している。そして、有棘層上層から顆粒層にかけてコーニファイドエンベロープ(CE)を構成する蛋白質が合成されている。さらに角層に至る過程で酵素トランスグルタミナーゼによってケラチノサイトの細胞膜にインボルクリン、ロリクリン、シスタチン等の基質蛋白質が結合し、不溶化したCEが形成される。さらに不溶化したCEにはセラミド等が共有結合し、角層バリア機能の基礎を形成することが知られている。   Here, the turnover refers to the repeated proliferation of keratinocytes (epidermal keratinocytes) in the basal layer, the process of keratinization, and the detachment of the stratum corneum. The keratinocytes form each layer while keratinizing sequentially toward the outside with basement membrane cells, spinous cells, granule cells, and horny layer cells. And the protein which comprises a cornified envelope (CE) is synthesize | combined from the spiny layer upper layer to the granule layer. Further, in the process of reaching the stratum corneum, substrate proteins such as involucrin, loricrin, cystatin and the like are bound to the cell membrane of keratinocytes by the enzyme transglutaminase to form insolubilized CE. Furthermore, it is known that ceramide and the like are covalently bonded to insolubilized CE and form the basis of the stratum corneum barrier function.

従来は、角層バリア機能の低下に起因する肌荒れ等の皮膚トラブルに対してセラミド等を含有したクリーム等で角層バリア機能を補うことにより解決してきた。しかし、角層細胞のCEの改善は十分でなく、健全なCEの形成を促進する成分の開発が望まれている。
上記基礎蛋白質のうちのインボルクリンは、上記のとおり角化不溶性膜の最外層に位置する構成蛋白質であり(非特許文献1)、他の角化不溶性膜の蛋白質、ロリクリン等と架橋されるだけでなく、セラミドと共有結合し、細胞間脂質ラメラ構造の形成関与していることが知られている(非特許文献2)。また、インボルクリンは表皮細胞の分化過程で特異的に細胞膜の近傍に、角化不溶性膜形成の前段階に産出され(非特許文献3)、表皮細胞分化マーカーとして着目されている。
Conventionally, a skin trouble such as rough skin due to a decrease in the stratum corneum barrier function has been solved by supplementing the stratum corneum barrier function with a cream containing ceramide or the like. However, the improvement of CE of stratum corneum cells is not sufficient, and the development of a component that promotes the formation of healthy CE is desired.
Of the basic proteins, involucrin is a constituent protein located in the outermost layer of the keratinized insoluble membrane as described above (Non-patent Document 1), and is merely cross-linked with proteins of other keratinized insoluble membranes, loricrin and the like. It is known that it is covalently bound to ceramide and involved in the formation of an intercellular lipid lamellar structure (Non-patent Document 2). Moreover, involucrin is produced in the vicinity of the cell membrane specifically in the differentiation process of epidermal cells and in the previous stage of keratinized insoluble film formation (Non-patent Document 3), and is attracting attention as an epidermal cell differentiation marker.

CEを形成しているインボルクリンの発現促進効果が認められるものとして、例えば、オトギリソウ科(Guttiferrae)のセイロンテツボク(Mesua Ferrea L.)(特許文献1)やアンズタケ属のクロラッパタケ(Craterellus cornucopioides)(特許文献2)が挙げられている。
特開2005−213187号公報 特開2005−89389号公報 Steinert, PM. Et al., J. Biol. Chem., 270(30), p17702-17711 (1995) Nemes, Z., Proc. Natl. Acad. Sci. USA, 96(15), p8402-8407 (1999) Steinert, PM. Et al., J. Biol. Chem., 272(3), p2021-2030 (1997)
Examples of the effects of promoting the expression of involucrin that forms CE include, for example, Mesua Ferrea L. (patent document 1) of Guttiferrae and Craterellus cornucopioides (patent document 1). Reference 2) is mentioned.
JP 2005-213187 A JP 2005-89389 A Steinert, PM. Et al., J. Biol. Chem., 270 (30), p17702-17711 (1995) Nemes, Z., Proc. Natl. Acad. Sci. USA, 96 (15), p8402-8407 (1999) Steinert, PM. Et al., J. Biol. Chem., 272 (3), p2021-2030 (1997)

本発明の目的は、インボルクリンの発現を促進し、角層細胞の角化を促進することができるインボルクリン発現促進剤及び角層形成促進剤を提供するものである。   An object of the present invention is to provide an involucrin expression promoter and a stratum corneum formation promoter that can promote the expression of involucrin and promote the cornification of horny layer cells.

本発明者らは、従来から食品等に用いられその安全性が確かめられている一定の植物からインボルクリンの発現を促進する植物又はその抽出物を見出し、本発明を完成した。   The present inventors have found a plant or extract thereof that promotes the expression of involucrin from certain plants that have been used in foods and the like and have been confirmed to be safe, and completed the present invention.

すなわち、本発明は、サンショウ、セイヨウハッカ、ユーカリ、ユキノシタ、ローズマリー、アスパラサス、ヒレハリソウ、シイタケ、ショウブ、イブキジャコウソウ、ワレモコウ、ガンビール、イチョウ、クズ、カリン、クチナシ、ビワ、アカキナノキ、サンザシ、チョウジノキ、ヨモギ及びキハダからなる群から選ばれる1種以上の植物又はその抽出物を含有するインボルクリン発現促進剤及び角層形成促進剤を提供するものである。   That is, the present invention includes: salamander, Atlantic mint, eucalyptus, saxifrage, rosemary, asparagus, sunflower, shiitake mushroom, ginger, ginkgo, currant, gardenia, loquat, red linden, hawthorn, The present invention provides an involucrin expression promoter and a stratum corneum formation promoter containing at least one plant selected from the group consisting of clove, mugwort and yellowfin, or an extract thereof.

本発明のインボルクリン発現促進剤及び角層形成促進剤によれば、優れたインボルクリンの産生促進能力を有し、角層細胞の角化を促進することにより健全な角層の形成を促すことで、皮膚バリア機能を健全にすることができる。   According to the involucrin expression promoter and the stratum corneum formation promoter of the present invention, it has excellent involucrin production promoting ability, and promotes the formation of a healthy stratum corneum by promoting cornification of the stratum corneum cells, The skin barrier function can be made healthy.

本発明で使用される植物のうちサンショウはミカン科のサンショウ(Zanthoxylum piperitum)、セイヨウハッカはシソ科のセイヨウハッカ(Juniperus communis var. communis)、ユーカリはフトモモ科のユーカリ(Eucalypus globulus)、ユキノシタはユキノシタ科のユキノシタ(Saxifraga sarmentosa)、ローズマリーはシソ科のローズマリー(Rosmarinus officinalis)、アスパラサスはマメ科のアスパラサス(Aspalathus linearis)、ヒレハリソウはムラサキ科のヒレハリソウ(Symphytum officinale)、シイタケは 科のシイタケ(Corthellus cuneata)、ショウブはショウブ科のショウブ(Acorus calamus)、イブキジャコウソウはシソ科のイブキジャコウソウ(Thymus serpyllum)、ワレモコウはバラ科のワレモコウ(Sanguisorba officinalis)、ガンビールはアカネ科のガンビール(Uncaria gambir)、イチョウはイチョウ科のイチョウ(Ginko biloba)、クズはマメ科のクズ(Pueraria lobata)、カリンはバラ科のカリン(Chaenomeles sinensis)、クチナシはアカネ科のクチナシ(Gardenia jasminoides)、ビワはバラ科のビワ(Eriobotrya japonica)、アカキナノキはアカネ科のアカキナノキ(Cinchona succirubra)、サンザシはバラ科のサンザシ(Crataegus cuneata)、チョウジノキはフトモモ科のチョウジノキ(Eugenia caryophyllus)、ヨモギはキク科のヨモギ(Artemisia princes)、キハダはミカン科のキハダ(Ephellodendron amurense Bark)である。   Among the plants used in the present invention, the salamander is Zanthoxylum piperitum, the mint is a Labiatae (Juniperus communis var. Communis), the eucalyptus is Eucalyptus eucalyptus (Eucalypus globulus), Is Saxifraga sarmentosa, Rosemary is Rosmarinus officinalis, Asparagus is Aspalathus linearis, Asperathus is Symphytum officinale, Symphytum officinale, Symphytum officinale Cortichellus cuneata, Acerus calamus, Acerus calamus, Thymus serpyllum (Uncaria gambir), Ichi Ginkgo biloba (Ginko biloba), Kudu (Pueraria lobata), Karin (Chaenomeles sinensis), Gardenia jademinoides (Gardenia jasminoides), and Loquat (Gardenia jasminoides) Biwa (Eriobotrya japonica), red lindens are Cinchona succirubra, hawthorn is rosaceae (Crataegus cuneata); The yellowfin is Ephellodendron amurense Bark.

本発明における植物は、葉、茎、芽、花、木質部、木皮部(樹皮)等の地上部及び根、塊茎等の地下部、種子、果実、樹脂等の部分が使用可能であるが、サンショウについては果実部を、セイヨウハッカについては葉部を、ユーカリについては葉部を、ユキノシタについては全草を、ローズマリーについては葉部を、アスパラサスについては葉部を、ヒレハリソウについては葉部を、シイタケについては子実体を、ショウブについては根部を、イブキジャコウソウについては葉部を、ワレモコウについては根部を、ガンビールについては樹皮・枝部を、イチョウについては葉部を、クズについては根部を、カリンについては果実部を、クチナシについては果実部を、ビワについては葉部を、アカキナノキについては樹皮部を、サンザシについては果実部を、チョウジノキについては蕾部を、ヨモギについては葉部を、キハダについては木皮部(樹皮)を用いるのが好ましい。   Plants in the present invention can be used in the above-ground parts such as leaves, stems, buds, flowers, woody parts, bark parts (bark), and underground parts such as roots and tubers, seeds, fruits, resins, etc. The fruit part for the show, the foliage for the mint, the foliage for the eucalyptus, the whole plant for the cypress, the foliage for the rosemary, the foliage for the asparagus, and the foliage for the spinach For shiitake mushrooms, roots for ginger, leaves for ginkgo biloba, roots for bitter gourd, bark / branches for gambir, leaves for ginkgo, roots for kudzu For Karin, the fruit part for gardenia, the fruit part for loquat, the leaf part for loquat, the bark part for red linden tree, and the hawthorn. The fruit portion, the bud part for Choujinoki, a leaf for wormwood, is preferably used bark portion (bark) for yellowfin.

本発明における植物は、植物そのまま若しくはそれら自身を圧搾することにより得られる搾汁、植物自身を乾燥した乾燥物若しくはその粉砕物、あるいはこれらから抽出した抽出物として用いることができるが、抽出物として用いるのが好ましい。   The plant in the present invention can be used as a plant as it is or by squeezing itself, a dried product obtained by drying the plant itself or a pulverized product thereof, or an extract extracted therefrom. It is preferable to use it.

斯かる植物の抽出物としては、上記植物を常温又は加温下にて抽出するか又はソックスレー抽出器等の抽出器具を用いて抽出すること等公知の抽出方法により得られる各種溶媒抽出液、その希釈液、その濃縮液又はその乾燥末が挙げられる。
公知の抽出方法としては、例えば、浸漬、煎出、浸出、還流抽出、超臨界抽出、超音波抽出及びマイクロ波抽出等が挙げられる。
Examples of such plant extracts include various solvent extracts obtained by a known extraction method such as extraction of the above plants at room temperature or under heating, or extraction using an extraction device such as a Soxhlet extractor, A diluted solution, a concentrated solution thereof or a dried powder thereof may be mentioned.
Known extraction methods include, for example, immersion, decoction, leaching, reflux extraction, supercritical extraction, ultrasonic extraction, and microwave extraction.

当該抽出物を得るために用いられる抽出溶剤としては、極性溶剤、非極性溶剤のいずれをも使用することができる。例えば、水;メタノール、エタノール、プロパノール、ブタノール等のアルコール類;プロピレングリコール、ブチレングリコール等の多価アルコール類;アセトン、メチルエチルケトン等のケトン類;酢酸メチル、酢酸エチル等のエステル類;テトラヒドロフラン、ジエチルエーテル等の鎖状及び環状エーテル類;ポリエチレングリコール等のポリエーテル類;ジクロロメタン、クロロホルム、四塩化炭素等のハロゲン化炭化水素類;ヘキサン、シクロヘキサン、石油エーテル等の炭化水素類;ベンゼン、トルエン等の芳香族炭化水素類;ピリジン類等が挙げられ、これらは単独又は混合物として用いることができる。このうち、特に水、アルコール系(アルコール類及び/又は多価アルコール類(V/V))溶剤、及び水−アルコール系混合溶剤を用いるのが好ましく、水−アルコール系混合溶剤(V/V)が好ましい。さらに、アルコール系はアルコール類が好ましく、アルコール類のうちメタノール、エタノール、プロパノールがより好ましく、エタノールが特に好ましい。   As the extraction solvent used for obtaining the extract, either a polar solvent or a nonpolar solvent can be used. For example, water; alcohols such as methanol, ethanol, propanol and butanol; polyhydric alcohols such as propylene glycol and butylene glycol; ketones such as acetone and methyl ethyl ketone; esters such as methyl acetate and ethyl acetate; tetrahydrofuran and diethyl ether Linear and cyclic ethers such as polyethylene; polyethers such as polyethylene glycol; halogenated hydrocarbons such as dichloromethane, chloroform and carbon tetrachloride; hydrocarbons such as hexane, cyclohexane and petroleum ether; aroma such as benzene and toluene Group hydrocarbons; pyridines and the like, and these can be used alone or as a mixture. Among these, it is particularly preferable to use water, alcohol-based (alcohols and / or polyhydric alcohols (V / V)) solvents, and water-alcohol mixed solvents, and water-alcohol mixed solvents (V / V). Is preferred. Furthermore, alcohols are preferably alcohols, and among alcohols, methanol, ethanol, and propanol are more preferable, and ethanol is particularly preferable.

本発明の植物原体からの抽出は、例えば以下の様に行う。
すなわち、植物1質量部に対して1〜50質量部の抽出溶剤を用い、4〜100℃にて0.5時間〜30日間抽出することにより行うことができる。
より具体的には、抽出溶剤として水を用いる場合には、植物1質量部に対して5〜20質量部、60〜80℃にて4〜6時間が好ましい。また、抽出溶剤として40〜60%エタノール水溶液を用いる場合には、植物1質量部に対して5〜30質量部、室温(特に4〜40℃の範囲)にて10〜30日が好ましい。また、75〜100%エタノール水溶液
を用いる場合には、植物1質量部に対して5〜20質量部、室温(特に4〜40℃の範囲)にて10〜30日が好ましい。
Extraction from the plant material of the present invention is performed as follows, for example.
That is, it can be performed by using 1 to 50 parts by mass of an extraction solvent with respect to 1 part by mass of the plant and extracting at 4 to 100 ° C. for 0.5 to 30 days.
More specifically, when water is used as the extraction solvent, 5 to 20 parts by mass and 60 to 80 ° C. for 4 to 6 hours are preferable with respect to 1 part by mass of the plant. Moreover, when using 40-60% ethanol aqueous solution as an extracting solvent, 10-30 days are preferable at 5-30 mass parts with respect to 1 mass part of plants, and room temperature (especially the range of 4-40 degreeC). Moreover, when using 75-100% ethanol aqueous solution, 10-30 days are preferable at 5-20 mass parts with respect to 1 mass part of plants, and room temperature (especially the range of 4-40 degreeC).

上記の抽出物は、そのまま用いることもできるが、当該抽出物を希釈、濃縮若しくは凍結乾燥した後、粉末又はペースト状に調製して用いることもできる。   The above extract can be used as it is, but it can also be used by diluting, concentrating or lyophilizing the extract and preparing it in a powder or paste form.

本発明の植物又はそれらの抽出物は、2種以上を混合して用いてもよい。また、前記抽出処理物の他、市販品を用いても良い。   Two or more kinds of the plants of the present invention or extracts thereof may be mixed and used. Moreover, you may use a commercial item other than the said extraction processed material.

また、上記抽出物は、さらに液々分配、固液分配、濾過膜、活性炭、吸収樹脂、イオン交換樹脂等の公知の技術によって不活性な夾雑物を除去して用いることが好ましい。このとき用いる溶剤は、上記の抽出溶剤の例示のものを用いてもよい。また、これらは、必要により公知の方法により脱臭、脱色等の処理を施してから用いてもよい。また、植物抽出物をさらに精製する際には、当該公知の技術及び方法を用いてもよい。   The extract is preferably used after removing inactive impurities by a known technique such as liquid-liquid distribution, solid-liquid distribution, filtration membrane, activated carbon, absorption resin, ion exchange resin and the like. As the solvent used at this time, those exemplified for the extraction solvent may be used. Moreover, you may use these, after giving processes, such as a deodorizing and a decoloring, by a well-known method as needed. Moreover, when further refine | purifying a plant extract, you may use the said well-known technique and method.

後記実施例で示すとおり、これら植物若しくは植物抽出物は、インボルクリンの発現を促進し、さらに角層形成を促進して皮膚バリア機能を健全にすることができる。このため、皮膚の水分保持能を改善し、肌荒れ防止効果、しわの形成、きめ模様減少、毛穴目立ち等の皮膚老化の予防改善が期待できる。このようなことから、これらを単独又は混合して含有するものは、化粧品、医薬部外品、及び医薬品等として使用可能なインボルクリン発現促進剤及び角層形成促進剤として用いることができる。当該製剤は、通常の皮膚表面の他に、脱毛処理後、さらには角層除去後に使用してもよい。   As shown in Examples below, these plants or plant extracts can promote the expression of involucrin, further promote the formation of the stratum corneum, and make the skin barrier function healthy. For this reason, the moisture retention ability of the skin is improved, and the prevention and improvement of skin aging such as the effect of rough skin prevention, the formation of wrinkles, the reduction of texture, and the conspicuous pores can be expected. Therefore, those containing these alone or in combination can be used as an involucrin expression promoter and horny layer formation promoter that can be used as cosmetics, quasi drugs, pharmaceuticals, and the like. In addition to the normal skin surface, the preparation may be used after depilation and further after removal of the stratum corneum.

本発明のインボルクリン発現促進剤及び角層形成促進剤は、軟膏等の薬用皮膚外用剤や化粧用皮膚外用剤の形態、具体的には、乳化化粧料、クリーム、乳液、ローション、ジェル等の種々の形態で用いることがとりわけ好ましい。斯かる上記製剤は、それぞれ一般的な製造法により、直接又は製剤上許容し得る担体とともに混合、分散した後、所望の形態に加工することによって得ることができる。この場合、本発明に用いられるこれら植物又はその抽出物の他に、かかる形態に一般的に用いられる植物油、動物油等の油性基剤、鎮痛消炎剤、鎮痛剤、殺菌消毒剤、収斂剤、皮膚軟化剤、ホルモン剤、ビタミン類、保湿剤、紫外線吸収剤、アルコール類、キレート剤、pH調整剤、防腐剤、増粘剤、色素、香料等を本発明の効果を妨害しない範囲で適宜配合することができる。
また本発明の上記製剤は、化粧料に限定されず、医薬品、医薬部外品、薬用化粧料等をも包含するものである。
The involucrin expression promoter and stratum corneum formation promoter of the present invention are in the form of medicinal skin external preparations such as ointments and cosmetic skin external preparations, specifically, various types of emulsion cosmetics, creams, emulsions, lotions, gels, etc. It is especially preferable to use in the form. Such a preparation can be obtained by mixing and dispersing directly or together with a pharmaceutically acceptable carrier and then processing into a desired form by a general production method. In this case, in addition to these plants or extracts thereof used in the present invention, oily bases such as vegetable oils and animal oils commonly used in such forms, analgesic anti-inflammatory agents, analgesics, bactericidal disinfectants, astringents, skin Softeners, hormones, vitamins, moisturizers, ultraviolet absorbers, alcohols, chelating agents, pH adjusters, preservatives, thickeners, dyes, fragrances, etc. are appropriately blended within a range that does not interfere with the effects of the present invention. be able to.
Moreover, the said formulation of this invention is not limited to cosmetics, A pharmaceutical, a quasi-drug, pharmaceutical cosmetics, etc. are included.

本発明の上記製剤におけるこれら植物又はその抽出物の単独又は混合の総配合量は、乾燥物として通常全組成の0.0001〜20質量%、特に0.001〜5質量%が好ましい。   The total amount of these plants or their extracts alone or mixed in the above-mentioned preparation of the present invention is usually 0.0001 to 20% by mass, particularly 0.001 to 5% by mass of the total composition as a dried product.

以下、実施例により本発明をさらに詳細に説明する。
製造例1 サンショウ抽出物の製造
サンショウの果実0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液4.5Lを得た(蒸発残分:1.2w/v%)。
Hereinafter, the present invention will be described in more detail with reference to examples.
Manufacture example 1 Manufacture of a salamander extract 5L of ion-exchange water was added to 0.5 kg of fruit of a salam, extracted at 70 degreeC for 5 hours, and then filtered to obtain 4.5L of an extract (residue of evaporation: 1. 2 w / v%).

製造例2 セイヨウハッカ抽出物の製造
セイヨウハッカの葉0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液3.2Lを得た(蒸発残分:2.4w/v%)。
Production Example 2 Production of mint mint extract 5 L of ion-exchanged water was added to 0.5 kg of mint leaf, extracted at 70 ° C. for 5 hours, and then filtered to obtain 3.2 L of an extract (residue of evaporation: 2. 4 w / v%).

製造例3 ユーカリ抽出物の製造
ユーカリの葉0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液4.5Lを得た(蒸発残分:2.2w/v%)。
Production Example 3 Production of Eucalyptus Extract 5 L of ion-exchanged water was added to 0.5 kg of eucalyptus leaves, extracted at 70 ° C. for 5 hours, and then filtered to obtain 4.5 L of an extract (evaporation residue: 2.2 w / v%).

製造例4 ユキノシタ抽出物の製造
ユキノシタの全草0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液3.3Lを得た(蒸発残分:2.2w/v%)。
Production Example 4 Production of Yukinoshita Extract 5 L of ion exchanged water was added to 0.5 kg of the whole plant of Yukinoshita, extracted at 70 ° C. for 5 hours, and then filtered to obtain 3.3 L of an extract (residue of evaporation: 2.2 w). / V%).

製造例5 ローズマリー抽出物の製造
ローズマリーの葉0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液4.0Lを得た(蒸発残分:1.9w/v%)
Production Example 5 Production of Rosemary Extract 5 L of ion-exchanged water was added to 0.5 kg of rosemary leaves, extracted at 70 ° C. for 5 hours, and then filtered to obtain 4.0 L of an extract (evaporation residue: 1. 9w / v%)

製造例6 アスパラサス抽出物の製造
アスパラサスの葉0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液3.8Lを得た(蒸発残分:1.2w/v%)
Production Example 6 Production of Asparagus Extract 5 L of ion-exchanged water was added to 0.5 kg of asparagus leaves, extracted at 70 ° C. for 5 hours, and filtered to obtain 3.8 L of an extract (residue of evaporation: 1. 2w / v%)

製造例7 ヒレハリソウ抽出物の製造
ヒレハリソウの葉0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液2.1Lを得た(蒸発残分:2.6w/v%)
Production Example 7 Production of cypress extract 5 kg of ion-exchanged water was added to 0.5 kg of cypress leaf and extracted at 70 ° C. for 5 hours, followed by filtration to obtain 2.1 L of an extract (evaporation residue: 2.6 w / v%)

製造例8 シイタケ抽出物の製造
シイタケの子実体0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液2.8Lを得た(蒸発残分:1.2w/v%)
Production Example 8 Production of shiitake extract 5 L of ion-exchanged water was added to 0.5 kg of shiitake fruiting body, extracted at 70 ° C. for 5 hours and filtered to obtain 2.8 L of an extract (residue of evaporation: 1.2 w). / V%)

製造例9 ショウブ抽出物の製造
ショウブの根0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液4.2Lを得た(蒸発残分:1.2w/v%)。
Production Example 9 Manufacture of Shobu Extract 5 L of ion-exchanged water was added to 0.5 kg of Shobu root, extracted at 70 ° C. for 5 hours, and then filtered to obtain 4.2 L of an extract (residue of evaporation: 1.2 w / v%).

製造例10 イブキジャコウソウ抽出物の製造
イブキジャコウソウの葉0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液4.2Lを得た(蒸発残分:1.2w/v%)。
Production Example 10 Manufacture of extract of Iris mussels 5 L of ion-exchanged water was added to 0.5 kg of Iris crickets, extracted at 70 ° C. for 5 hours, and then filtered to obtain 4.2 L of an extract (residue of evaporation: 1. 2 w / v%).

製造例11 ワレモコウ抽出物の製造
ワレモコウの根0.5kgにイオン交換水5Lを加え、70℃で5時間抽出後、濾過して抽出液3.8Lを得た(蒸発残分:0.7w/v%)。
Production Example 11 Production of Warmoko Extract 5 kg of ion-exchanged water was added to 0.5 kg of root of Warmoko, followed by extraction at 70 ° C. for 5 hours, followed by filtration to obtain 3.8 L of an extract (residue of evaporation: 0.7 w / v%).

製造例12 ガンビール抽出物の製造
ガンビールの樹皮および枝0.2kgに50%(v/v)エタノール水溶液2Lを加え、室温で13日間抽出後、濾過して抽出液1.8Lを得た(蒸発残分:7.4w/v%)。
Production Example 12 Production of Gum Beer Extract 2 L of 50% (v / v) ethanol aqueous solution was added to 0.2 kg of Gum beer bark and branches, extracted for 13 days at room temperature, and filtered to obtain 1.8 L of an extract. (Evaporation residue: 7.4 w / v%).

製造例13 イチョウ抽出物の製造
イチョウの葉0.2kgに50%(v/v)エタノール水溶液2Lを加え、室温で13日間抽出後、濾過して抽出液1.5Lを得た(蒸発残分:2.7w/v%)。
Production Example 13 Production of Ginkgo Biloba Extract 2 kg of 50% (v / v) aqueous ethanol solution was added to 0.2 kg of Ginkgo biloba leaves, extracted at room temperature for 13 days, and then filtered to obtain 1.5 L of extract (evaporation residue). : 2.7 w / v%).

製造例14 クズ抽出物の製造
クズの根0.2kgに50%(v/v)エタノール水溶液2Lを加え、室温で14日間抽出後、濾過して抽出液1.6Lを得た(蒸発残分:1.8w/v%)。
Production Example 14 Production of Kuzu Extract 2 L of 50% (v / v) ethanol aqueous solution was added to 0.2 kg of Kuzu root, extracted at room temperature for 14 days and filtered to obtain 1.6 L of an extract (evaporation residue). : 1.8 w / v%).

製造例15 カリン抽出物の製造
カリンの果実0.2kgに50%(v/v)エタノール水溶液2Lを加え、室温で14日間抽出後、濾過して抽出液1.7Lを得た(蒸発残分:2.8w/v%)。
Production Example 15 Production of Karin Extract 2 L of 50% (v / v) ethanol aqueous solution was added to 0.2 kg of karin fruit, extracted at room temperature for 14 days, and filtered to obtain 1.7 L of an extract (residue from evaporation). : 2.8 w / v%).

製造例16 クチナシ抽出物の製造
クチナシの果実0.2kgに50%(v/v)エタノール水溶液2Lを加え、室温で14日間抽出後、濾過して抽出液1.7Lを得た(蒸発残分:2.7w/v%)。
Production Example 16 Production of gardenia extract 2 L of 50% (v / v) ethanol aqueous solution was added to 0.2 kg of gardenia fruit, extracted at room temperature for 14 days, and filtered to obtain 1.7 L of an extract (evaporation residue). : 2.7 w / v%).

製造例17 ビワ抽出物の製造
ビワの葉0.2kgに50%(v/v)エタノール水溶液2Lを加え、室温で20日間抽出後、濾過して抽出液1.4Lを得た(蒸発残分:1.7w/v%)。
Production Example 17 Production of loquat extract 2 L of 50% (v / v) ethanol aqueous solution was added to 0.2 kg of loquat leaves, extracted at room temperature for 20 days, and filtered to obtain 1.4 L of an extract (evaporation residue). : 1.7 w / v%).

製造例18 アカキナノキ抽出物の製造
アカキナノキの樹皮0.2kgに50%(v/v)エタノール水溶液10Lを加え、室温で19日間抽出後、濾過して抽出液1.6Lを得た(蒸発残分:1.8w/v%)。
Production Example 18 Production of red linden extract 10 kg of 50% (v / v) ethanol aqueous solution was added to 0.2 kg of red linden bark, extracted at room temperature for 19 days, and filtered to obtain 1.6 L of an extract (residue from evaporation) : 1.8 w / v%).

製造例19 サンザシ抽出物の製造
サンザシの果実0.2kgに50%(v/v)エタノール水溶液2Lを加え、室温で15日間抽出後、濾過して抽出液1.7Lを得た(蒸発残分:1.2w/v%)。
Production Example 19 Production of Hawthorn Extract 2 L of 50% (v / v) ethanol aqueous solution was added to 0.2 kg of hawthorn fruit, extracted at room temperature for 15 days, and filtered to obtain 1.7 L of an extract (evaporation residue). : 1.2 w / v%).

製造例20 チョウジノキ抽出物の製造
チョウジノキの蕾0.2kgに95%(v/v)エタノール水溶液2Lを加え、室温で18日間抽出後、抽出液1.9Lを得た(蒸発残分:0.8w/v%)。
Manufacture example 20 Manufacture of a cinnamon extract 2 L of 95% (v / v) ethanol aqueous solution was added to 0.2 kg of a cinnamon mushroom, and after extraction for 18 days at room temperature, 1.9 L of an extract was obtained (evaporation residue: 0.0. 8 w / v%).

製造例21 ヨモギ抽出物の製造
ヨモギの葉0.2kgに95%(v/v)エタノール水溶液2Lを加え、室温で15日間抽出後、濾過して抽出液1.4Lを得た(蒸発残分:0.7w/v%)。
Production Example 21 Production of Artemisia Extract 2 L of mugwort leaves was added with 2 L of 95% (v / v) ethanol aqueous solution and extracted at room temperature for 15 days, followed by filtration to obtain 1.4 L of extract (evaporation residue). : 0.7 w / v%).

製造例22 キハダ抽出物の製造
キハダの樹皮1.0kgに50%(v/v)エタノール水溶液10Lを加え、室温で7日間抽出後、濾過して抽出液を得た(蒸発残分:1.2(w/v%)。
Production Example 22 Production of yellowfin extract 10 kg of 50% (v / v) aqueous ethanol solution was added to 1.0 kg of yellowfin bark, extracted for 7 days at room temperature, and filtered to obtain an extract (evaporation residue: 1. 2 (w / v%).

製造例23 キハダ抽出物の精製
キハダの樹皮1.0kgに50%(v/v)エタノール水溶液10Lを加え、室温で7日間抽出後、濾過して抽出液を得た(蒸発残分:1.2(w/v%)。得られた抽出液に、活性炭(日本エンバイロケミカルズ社、白鷺A)を加え、室温下で1時間撹拌処理した後ろ過した。得られたろ液を冷温(4℃前後)下で1週間静置し、析出した不溶成分を除去して精製品とした(蒸発残分:0.19(w/v%)。
Production Example 23 Purification of yellowfin extract 10 kg of 50% (v / v) aqueous ethanol solution was added to 1.0 kg of yellowfin bark, extracted at room temperature for 7 days, and filtered to obtain an extract (evaporation residue: 1. 2 (w / v%) Activated carbon (Nippon EnviroChemicals, Shirasagi A) was added to the resulting extract, and the mixture was stirred at room temperature for 1 hour and then filtered. ) For 1 week, and the precipitated insoluble components were removed to obtain a purified product (evaporation residue: 0.19 (w / v%)).

製造例24 キハダ抽出物疎水性画分の製造
キハダの樹皮1.0kgに95%(v/v)エタノール水溶液10Lを加え、室温で7日間抽出後、濾過して抽出液を得た。この抽出液を減圧濃縮後、得られた残渣にヘキサン0.6Lを加えて室温下7日間抽出した後濾過し、ヘキサン抽出液を得た。これを減圧濃縮し、さらに減圧乾燥して、キハダエキス疎水性画分を得た(蒸発残分:1.0(w/v%)。
Production Example 24 Production of hydrophobic fraction of yellowfin extract 10 kg of 95% (v / v) aqueous ethanol solution was added to 1.0 kg of yellowfin bark, extracted for 7 days at room temperature, and filtered to obtain an extract. After concentration of this extract under reduced pressure, 0.6 L of hexane was added to the resulting residue, followed by extraction at room temperature for 7 days, followed by filtration to obtain a hexane extract. This was concentrated under reduced pressure and further dried under reduced pressure to obtain a yellowfin extract hydrophobic fraction (evaporation residue: 1.0 (w / v%)).

以下の表1に各抽出物製造に用いた植物の部位、溶媒をまとめる。   Table 1 below summarizes the plant parts and solvents used in the production of each extract.

Figure 2007277149
Figure 2007277149

実施例1 ケラチノサイト角化亢進作用
ケラチノサイト用培地(Epi Life:クラボウ)を用いてケラチノサイト(HEKn:Cascade Biologics)を2×104 cells/cm2で12well プレートに播種し、24時間培養した後、製造例1〜24で得られた植物の抽出物を1μL/mLずつ添加した。添加24時間後にスクレーパーで細胞を回収し、緩衝液(例えばRIPA等)で細胞抽出液を調整した。得られた細胞抽出液のタンパク質量を測定し(PIERCE:BCA Protein Assay Reagent Kit)、等量をSDS-PAGEにて分離、ケラチノサイトの角化マーカーの一つであるインボルクリン抗体を用いて、ウェスタンブロッティングを行った。得られたバンドを画像解析ソフトLane & Spot Analyzer 5.0 (ATTO社)にて定量した。
コントロール(エキス無添加)におけるインボルクリン発現量を100%とした時の発現量を求めた。結果を表2に示す。
Example 1 Keratinocyte keratinization enhancing action Keratinocytes (HEKn: Cascade Biologics) were seeded on a 12-well plate at 2 × 10 4 cells / cm 2 using a culture medium for keratinocytes (Epi Life: Kurabo Industries), and cultured for 24 hours. The plant extract obtained in Examples 1 to 24 was added in an amount of 1 μL / mL. 24 hours after the addition, the cells were collected with a scraper, and the cell extract was prepared with a buffer solution (for example, RIPA). Measure the amount of protein in the resulting cell extract (PIERCE: BCA Protein Assay Reagent Kit), separate the same amount with SDS-PAGE, Western blotting using involucrin antibody, one of the keratinocyte keratinization markers Went. The obtained bands were quantified with image analysis software Lane & Spot Analyzer 5.0 (ATTO).
The expression level when the involucrin expression level in the control (no extract added) was taken as 100% was determined. The results are shown in Table 2.

Figure 2007277149
Figure 2007277149

実施例2 水分保持機能改善作用及び毛穴目立ち改善作用
(1)キハダ抽出物活性炭処理物の塗布
サンプルとしてキハダ抽出物活性炭処理物(蒸発残分:0.19(w/v)溶媒50%エタノール)を3%含む溶液(溶媒95%エタノール:1.3−グリセリルエーテル:精製水=2:1:7)を用い、キハダ抽出物活性炭処理物を含まない溶液をプラセボとして用いた。健常成人男性8名の頬部にハーフフェイスで、片側にキハダ抽出物活性炭処理物を含むサンプル、片側にこれを含まないプラセボを4週間、1日2回、1回約60μL、途布した。
Example 2 Moisture retention function improving effect and pore conspicuous improving effect (1) Application of yellowfin extract activated carbon treated product Yellowfin extract activated carbon treated sample (evaporation residue: 0.19 (w / v) solvent 50% ethanol) as a sample Was used (solvent 95% ethanol: 1.3-glyceryl ether: purified water = 2: 1: 7), and a solution containing no treated charcoal extract was used as a placebo. A sample of 8 healthy adult males with a half face on one cheek, a sample containing a charcoal extract-treated product on one side, and a placebo not containing this on one side were distributed twice a day for about 60 μL once a day for 4 weeks.

(2)皮膚の水分保持能改善効果の確認
塗布開始前と塗布4週間経過後に角層水分量の測定を行った。角層水分量の測定はコルネオメーター(C+K社)を用いて行い、7回測定を行った最大、最小値を除く5回の平均値で求めた。0週目の測定値はサンプル側プラセボ側に有意な差が無いのに対し、塗布4週間経過後の角層水分量はプラセボ途布側と比べ、サンプル途布側で有意な上昇が認められた。(t-test P<0.05)(図1は4週目の測定値を示す。)。
(2) Confirmation of improvement effect of skin water retention ability The stratum corneum moisture content was measured before the start of application and after 4 weeks of application. The stratum corneum moisture content was measured using a Corneometer (C + K), and the average value of 5 times excluding the maximum and minimum values measured 7 times. There is no significant difference between the measured value at the 0th week on the sample placebo side, whereas the stratum corneum water content after 4 weeks of application is significantly increased on the sample spreading side compared to the placebo spreading side. It was. (t-test P <0.05) (FIG. 1 shows measured values at 4 weeks).

(3)毛穴目立ち改善効果の確認
塗布開始前と塗布4週間経過後に、シリコーン印象剤(ASB−01:アサヒバイオメッド社)にて同一部位から皮膚表面形状のネガティブレプリカを採取した。採取したレプリカをビデオマイクロスコープ(PV−10:オリンパス社)にてデジタル画像として取り込んだ。取り込んだ画像からの毛穴周囲の凹み面積の測定は、画像解析ソフト:Image Pro-plus(Media Cybanetics社)を用いて、取り込んだ画像を8ビットグレイスケールに変換し、閾値100で二値化し、その後残った成分から毛穴以外のものを除去し、面積0.02mm2以上のものを毛穴周囲の凹み面積として測定した。得られた平均毛穴面積の0週から4週の変化率(途布4週間後の平均毛穴面積/途布開始前(0週)の平均毛穴面積)を求めた(図2)。塗布4週間経過後の毛穴周囲の凹み面積は塗布前に比して約9%減少していた(t-test P<0.05)。
(3) Confirmation of pore conspicuousness improvement effect A negative replica of the skin surface shape was collected from the same site with a silicone impression agent (ASB-01: Asahi Biomed) before the start of application and after 4 weeks of application. The collected replica was captured as a digital image with a video microscope (PV-10: Olympus). Using the image analysis software: Image Pro-plus (Media Cybanetics), the captured image is converted to 8-bit gray scale and binarized with a threshold of 100. Thereafter, the components other than the pores were removed from the remaining components, and those having an area of 0.02 mm 2 or more were measured as the recessed area around the pores. The rate of change of the obtained average pore area from week 0 to week 4 (average pore area after 4 weeks of distribution / average pore area before the start of distribution (week 0)) was determined (FIG. 2). The depression area around the pores after 4 weeks of application was reduced by about 9% compared to before application (t-test P <0.05).

キハダ抽出物活性炭処理物の添加溶液(サンプル)及び無添加溶液(プラセボ)の塗布による角層水分量の変化(塗布後4週目の測定値を示す)。Change in stratum corneum moisture content by application of an additive solution (sample) and an additive-free solution (placebo) of the processed powdered charcoal extract (showing measured values at 4 weeks after application). キハダ抽出物活性炭処理物の添加溶液(サンプル)及び無添加溶液(プラセボ)塗布による毛穴平均面積の変化(0週と4週の同一毛穴群における平均面積の変化率示す)。Change in average pore area due to application of yellowfin extract activated carbon treated product (sample) and non-addition solution (placebo) (indicating rate of change in average area in the same pore group at 0 and 4 weeks).

Claims (2)

サンショウ、セイヨウハッカ、ユーカリ、ユキノシタ、ローズマリー、アスパラサス、ヒレハリソウ、シイタケ、ショウブ、イブキジャコウソウ、ワレモコウ、ガンビール、イチョウ、クズ、カリン、クチナシ、ビワ、アカキナノキ、サンザシ、チョウジノキ、ヨモギ、及びキハダからなる群から選ばれる1種以上の植物又はその抽出物を含有するインボルクリン発現促進剤。   Salamander, Atlantic mint, Eucalyptus, Saxifrage, Rosemary, Asparagus, Cypress, Shiitake mushroom, Shobu, Ibusuki Sou, Walnut, Gambir, Ginkgo, Kudzu, Karin, Gardenia, Biwa, Red linden, Hawthorn, Crested cypress, Artemisia, Artemisia An involucrin expression promoter containing at least one plant selected from the group consisting of or an extract thereof. サンショウ、セイヨウハッカ、ユーカリ、ユキノシタ、ローズマリー、アスパラサス、ヒレハリソウ、シイタケ、ショウブ、イブキジャコウソウ、ワレモコウ、ガンビール、イチョウ、クズ、カリン、クチナシ、ビワ、アカキナノキ、サンザシ、チョウジノキ、ヨモギ、及びキハダからなる群から選ばれる1種以上の植物又はその抽出物を含有する角層形成促進剤。   Salamander, Atlantic mint, Eucalyptus, Saxifrage, Rosemary, Asparagus, Cypress, Shiitake mushroom, Shobu, Ibusuki Sou, Walnut, Gambir, Ginkgo, Kudzu, Karin, Gardenia, Biwa, Red linden, Hawthorn, Crested cypress, Artemisia, Artemisia A stratum corneum formation promoter containing at least one plant selected from the group consisting of or an extract thereof.
JP2006105204A 2006-04-06 2006-04-06 Involucrin expression promoter Pending JP2007277149A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006105204A JP2007277149A (en) 2006-04-06 2006-04-06 Involucrin expression promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006105204A JP2007277149A (en) 2006-04-06 2006-04-06 Involucrin expression promoter

Publications (1)

Publication Number Publication Date
JP2007277149A true JP2007277149A (en) 2007-10-25

Family

ID=38678982

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006105204A Pending JP2007277149A (en) 2006-04-06 2006-04-06 Involucrin expression promoter

Country Status (1)

Country Link
JP (1) JP2007277149A (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009084195A (en) * 2007-09-28 2009-04-23 Naris Cosmetics Co Ltd Involucrin production promoter
JP2009242310A (en) * 2008-03-31 2009-10-22 Kose Corp Involucrin production promoter, transglutaminase-1 production promoter, e-cadherin production promoter and skin care preparation for external use for making skin pore inconspicuous
JP2009256271A (en) * 2008-04-18 2009-11-05 Maruzen Pharmaceut Co Ltd AQUAPORIN 3 mRNA EXPRESSION PROMOTOR AND SKIN MOISTURE RETENTION FUNCTION-IMPROVING AGENT
JP2009256244A (en) * 2008-04-17 2009-11-05 Maruzen Pharmaceut Co Ltd Claudin production promoter, occludin production promoter and skin barrier function-improving agent
WO2012115247A1 (en) * 2011-02-25 2012-08-30 株式会社資生堂 Stratum corneum peeling accelerator
JP2012171949A (en) * 2011-02-24 2012-09-10 Nagase & Co Ltd Expression enhancer of melatonin receptor and method for producing the same
WO2012144080A1 (en) * 2011-04-22 2012-10-26 大学共同利用機関法人自然科学研究機構 Skin barrier function improving agent
JP2012232920A (en) * 2011-04-28 2012-11-29 Maruzen Pharmaceut Co Ltd HEXOSAMINIDASE RELEASE INHIBITOR, STEM CELL GROWTH FACTOR mRNA EXPRESSION ELEVATION INHIBITOR, PROPHYLACTIC AND AMELIORATING AGENT OF HYDROGEN-PEROXIDE CYTOPATHY AND GLUTATHIONE PRODUCTION PROMOTOR
JP2013023438A (en) * 2011-07-15 2013-02-04 Mikimoto Pharmaceut Co Ltd Cornification promoter, filaggrin production promoter, loricrin production promoter, padi-1 production promoter, and histidase production promoter
JPWO2011040496A1 (en) * 2009-09-30 2013-02-28 株式会社 資生堂 Heparanase activity inhibitor
JPWO2011122041A1 (en) * 2010-03-31 2013-07-04 株式会社 資生堂 Expression regulator of clock gene Period
JP2014129267A (en) * 2012-12-28 2014-07-10 Kose Corp DNA damage inhibitor
JP2015044788A (en) * 2013-07-29 2015-03-12 株式会社コーセー Epidermal stem cellularity maintenance agent containing acorus calamus extract
FR3032120A1 (en) * 2015-02-04 2016-08-05 Lvmh Rech COSMETIC USE OF PEPPER MINT EXTRACT
JP2017186284A (en) * 2016-04-07 2017-10-12 ポーラ化成工業株式会社 Proteoglycan production promoter
JP2018104322A (en) * 2016-12-26 2018-07-05 サンスター株式会社 Skin barrier function intensifying or improving composition
JP2018127407A (en) * 2017-02-07 2018-08-16 日華化学株式会社 Epidermis normalization agent as well as external preparations and cosmetics containing the same
JP2018203677A (en) * 2017-06-06 2018-12-27 花王株式会社 Procollagen processing promoter
JP2020111540A (en) * 2019-01-12 2020-07-27 株式会社桃谷順天館 Kallikrein 7 precursor production promoter by plant-derived extract, kallikrein 7 activity promoter, epidermal keratinocyte proliferation agent, stratum corneum-thickening improving agent, turnover improver, skin elasticity improver, or hyperkeratosis improver
JP2020174543A (en) * 2019-04-16 2020-10-29 日本メナード化粧品株式会社 Differentiation promoter of epidermal stem cell
JP2020182415A (en) * 2019-05-08 2020-11-12 日本メナード化粧品株式会社 Agent for promoting differentiation of dermal stem cell
JP2021038168A (en) * 2019-09-03 2021-03-11 ちふれホールディングス株式会社 Composition for suppressing deterioration of skin barrier function
KR102567330B1 (en) * 2023-06-23 2023-08-17 (주)더마랩 Cosmetic composition comprising plant complex extract containing Kummerowia striata extract as an active ingredient
JP7460134B2 (en) 2019-05-23 2024-04-02 ポーラ化成工業株式会社 Desmoglein reducer

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1179968A (en) * 1997-09-04 1999-03-23 Kao Corp Cosmetic
JP2000136146A (en) * 1998-11-02 2000-05-16 Shiseido Co Ltd Protease inhibitor
JP2001261543A (en) * 2000-03-17 2001-09-26 Kao Corp Skin cosmetic
JP2001288066A (en) * 2000-03-31 2001-10-16 Shiseido Co Ltd Skin barrier function ameliorator
WO2002053127A1 (en) * 2000-12-28 2002-07-11 Shiseido Company, Ltd. Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same
JP2003026560A (en) * 2001-07-12 2003-01-29 Kanebo Ltd Activated oxygen-eliminating agent, skin cosmetic material for preventing aging, and method for stabilizing activated oxygen-eliminating activity
JP2003104886A (en) * 2001-09-28 2003-04-09 Lion Corp Skin care composition
JP2003171310A (en) * 2002-05-02 2003-06-20 Noevir Co Ltd Skin barrier function-reinforcing agent
JP2003306438A (en) * 2002-02-18 2003-10-28 Shiseido Co Ltd Chemokine expression inhibitor
JP2005213187A (en) * 2004-01-29 2005-08-11 Kose Corp Involucrin production promoter
JP2005298403A (en) * 2004-04-12 2005-10-27 Kao Corp Skin cosmetic
JP2006016337A (en) * 2004-07-01 2006-01-19 Maruzen Pharmaceut Co Ltd Filaggrin production-accelerating agent and skin cosmetic

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1179968A (en) * 1997-09-04 1999-03-23 Kao Corp Cosmetic
JP2000136146A (en) * 1998-11-02 2000-05-16 Shiseido Co Ltd Protease inhibitor
JP2001261543A (en) * 2000-03-17 2001-09-26 Kao Corp Skin cosmetic
JP2001288066A (en) * 2000-03-31 2001-10-16 Shiseido Co Ltd Skin barrier function ameliorator
WO2002053127A1 (en) * 2000-12-28 2002-07-11 Shiseido Company, Ltd. Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same
JP2003026560A (en) * 2001-07-12 2003-01-29 Kanebo Ltd Activated oxygen-eliminating agent, skin cosmetic material for preventing aging, and method for stabilizing activated oxygen-eliminating activity
JP2003104886A (en) * 2001-09-28 2003-04-09 Lion Corp Skin care composition
JP2003306438A (en) * 2002-02-18 2003-10-28 Shiseido Co Ltd Chemokine expression inhibitor
JP2003171310A (en) * 2002-05-02 2003-06-20 Noevir Co Ltd Skin barrier function-reinforcing agent
JP2005213187A (en) * 2004-01-29 2005-08-11 Kose Corp Involucrin production promoter
JP2005298403A (en) * 2004-04-12 2005-10-27 Kao Corp Skin cosmetic
JP2006016337A (en) * 2004-07-01 2006-01-19 Maruzen Pharmaceut Co Ltd Filaggrin production-accelerating agent and skin cosmetic

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009084195A (en) * 2007-09-28 2009-04-23 Naris Cosmetics Co Ltd Involucrin production promoter
JP2009242310A (en) * 2008-03-31 2009-10-22 Kose Corp Involucrin production promoter, transglutaminase-1 production promoter, e-cadherin production promoter and skin care preparation for external use for making skin pore inconspicuous
JP2009256244A (en) * 2008-04-17 2009-11-05 Maruzen Pharmaceut Co Ltd Claudin production promoter, occludin production promoter and skin barrier function-improving agent
JP2009256271A (en) * 2008-04-18 2009-11-05 Maruzen Pharmaceut Co Ltd AQUAPORIN 3 mRNA EXPRESSION PROMOTOR AND SKIN MOISTURE RETENTION FUNCTION-IMPROVING AGENT
JPWO2011040496A1 (en) * 2009-09-30 2013-02-28 株式会社 資生堂 Heparanase activity inhibitor
US8901160B2 (en) 2009-09-30 2014-12-02 Shiseido Company, Ltd. Heparanase activity inhibitor
JP5593323B2 (en) * 2009-09-30 2014-09-24 株式会社 資生堂 Heparanase activity inhibitor
US8609075B2 (en) 2009-09-30 2013-12-17 Shiseido Company, Ltd. Heparanase activity inhibitor
JP2014111640A (en) * 2009-09-30 2014-06-19 Shiseido Co Ltd Heparanase activity inhibitor
JP5868313B2 (en) * 2010-03-31 2016-02-24 株式会社 資生堂 Expression regulator of clock gene Period
JPWO2011122041A1 (en) * 2010-03-31 2013-07-04 株式会社 資生堂 Expression regulator of clock gene Period
JP2012171949A (en) * 2011-02-24 2012-09-10 Nagase & Co Ltd Expression enhancer of melatonin receptor and method for producing the same
WO2012115247A1 (en) * 2011-02-25 2012-08-30 株式会社資生堂 Stratum corneum peeling accelerator
JP5737663B2 (en) * 2011-04-22 2015-06-17 大学共同利用機関法人自然科学研究機構 Skin barrier function improver
JPWO2012144080A1 (en) * 2011-04-22 2014-07-28 大学共同利用機関法人自然科学研究機構 Skin barrier function improver
WO2012144080A1 (en) * 2011-04-22 2012-10-26 大学共同利用機関法人自然科学研究機構 Skin barrier function improving agent
JP2012232920A (en) * 2011-04-28 2012-11-29 Maruzen Pharmaceut Co Ltd HEXOSAMINIDASE RELEASE INHIBITOR, STEM CELL GROWTH FACTOR mRNA EXPRESSION ELEVATION INHIBITOR, PROPHYLACTIC AND AMELIORATING AGENT OF HYDROGEN-PEROXIDE CYTOPATHY AND GLUTATHIONE PRODUCTION PROMOTOR
JP2013023438A (en) * 2011-07-15 2013-02-04 Mikimoto Pharmaceut Co Ltd Cornification promoter, filaggrin production promoter, loricrin production promoter, padi-1 production promoter, and histidase production promoter
JP2014129267A (en) * 2012-12-28 2014-07-10 Kose Corp DNA damage inhibitor
JP2015044788A (en) * 2013-07-29 2015-03-12 株式会社コーセー Epidermal stem cellularity maintenance agent containing acorus calamus extract
EP3253457B1 (en) * 2015-02-04 2021-03-31 LvmH Recherche Cosmetic use of a pepermint extract
FR3032120A1 (en) * 2015-02-04 2016-08-05 Lvmh Rech COSMETIC USE OF PEPPER MINT EXTRACT
JP2018505883A (en) * 2015-02-04 2018-03-01 エルヴェエムアッシュ ルシェルシュ Use of peppermint extract in cosmetics
WO2016124862A1 (en) * 2015-02-04 2016-08-11 Lvmh Recherche Cosmetic use of a peppermint extract
US10413502B2 (en) 2015-02-04 2019-09-17 Lvmh Recherche Cosmetic use of a peppermint extract
JP2017186284A (en) * 2016-04-07 2017-10-12 ポーラ化成工業株式会社 Proteoglycan production promoter
JP2018104322A (en) * 2016-12-26 2018-07-05 サンスター株式会社 Skin barrier function intensifying or improving composition
JP2018127407A (en) * 2017-02-07 2018-08-16 日華化学株式会社 Epidermis normalization agent as well as external preparations and cosmetics containing the same
JP7053169B2 (en) 2017-06-06 2022-04-12 花王株式会社 Procollagen processing accelerator
JP2018203677A (en) * 2017-06-06 2018-12-27 花王株式会社 Procollagen processing promoter
JP2020111540A (en) * 2019-01-12 2020-07-27 株式会社桃谷順天館 Kallikrein 7 precursor production promoter by plant-derived extract, kallikrein 7 activity promoter, epidermal keratinocyte proliferation agent, stratum corneum-thickening improving agent, turnover improver, skin elasticity improver, or hyperkeratosis improver
JP2020174543A (en) * 2019-04-16 2020-10-29 日本メナード化粧品株式会社 Differentiation promoter of epidermal stem cell
JP7281801B2 (en) 2019-04-16 2023-05-26 日本メナード化粧品株式会社 Epidermal stem cell differentiation promoter
JP2020182415A (en) * 2019-05-08 2020-11-12 日本メナード化粧品株式会社 Agent for promoting differentiation of dermal stem cell
JP7365664B2 (en) 2019-05-08 2023-10-20 日本メナード化粧品株式会社 Dermal stem cell differentiation promoter
JP7460134B2 (en) 2019-05-23 2024-04-02 ポーラ化成工業株式会社 Desmoglein reducer
JP2021038168A (en) * 2019-09-03 2021-03-11 ちふれホールディングス株式会社 Composition for suppressing deterioration of skin barrier function
JP7382181B2 (en) 2019-09-03 2023-11-16 ちふれホールディングス株式会社 Composition for suppressing skin barrier function decline
KR102567330B1 (en) * 2023-06-23 2023-08-17 (주)더마랩 Cosmetic composition comprising plant complex extract containing Kummerowia striata extract as an active ingredient

Similar Documents

Publication Publication Date Title
JP2007277149A (en) Involucrin expression promoter
JP5791879B2 (en) NF-κB activation inhibitor and pore care agent
JP2008007411A (en) Transglutaminase production promoter and epidermal keratinization-normalizing agent
KR20170053388A (en) Cosmetic composition comprising mixture extracts of curcuma longa Linn, apple, grape, having anti-pollution effect in skin cells and method manufacturing thereof
JP2814094B2 (en) Cosmetics containing acerola extract
JP5858727B2 (en) Involucrin expression promoter
KR101512064B1 (en) Method for manufacturing functional cosmetic composite using no allergic bee venom
JP2009084169A (en) Xanthone derivative exhibiting collagen-producing activity and method for producing the same
JP5858726B2 (en) Involucrin expression inhibitor
JP2006131558A (en) Collagen formation enhancer
JP2009185007A (en) Promoting agent for production of keratinocyte growth factor
JP2012025777A (en) Vascularization inhibitor and external preparation
JPH07238011A (en) Skin-beautifying cosmetic composition
JP6901256B2 (en) Epithelial cell activator
JP2009114146A (en) Transglutaminase-1 production promoter and involucrin production promoter
JP5903251B2 (en) Involucrin expression promoter
JP6386773B2 (en) Hair restorer
JP6904688B2 (en) Epithelial cell activator
JP5946698B2 (en) Whitening agent and skin cosmetics
JP6417114B2 (en) Involucrin expression inhibitor
JP2018070524A (en) Epidermal cell activator
JP2008031089A (en) Scf binding inhibitor
JP2008013522A (en) Cell growth promoter
JP6417113B2 (en) Involucrin expression inhibitor
KR101528203B1 (en) Cosmetic composition for skin moisturizing comprising the extract of grateloupia filicina as active ingredient

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071026

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100622

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101026